IT

ITOXI Corp.

B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.

052770 | KO

Overview

Corporate Details

ISIN(s):
KR7052770005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 도산대로 427 파모소빌딩 4층, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ITOXI Corp. is a diversified corporation, formerly known as YD Online Corp, with a history in the online and mobile game development industry. The company has expanded its business scope to include international business promotion and strategic partnership development. A key division, ITOXI UA, operates as a B2B platform facilitating cooperation, trade, and investment between Ukrainian and Korean companies. This platform offers end-to-end services including market research, partner sourcing and vetting, negotiation support, and project implementation for joint ventures and investment projects, with a particular focus on Ukraine's post-war reconstruction.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Delisting Announcement
주권매매거래정지 (자본감소)
Korean 4.7 KB
2025-09-08 00:00
Share Issue/Capital Change
주요사항보고서(감자결정)
Korean 15.7 KB
2025-09-08 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.0 KB
2025-09-08 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-09-08 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(감자결정)
Korean 18.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.5 KB
2025-08-13 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.5 MB
2025-08-12 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 51.2 KB
2025-06-12 00:00
Share Issue/Capital Change
[정정명령부과][기재정정]주요사항보고서(전환사채권발행결정)
Korean 52.9 KB
2025-06-12 00:00
Share Issue/Capital Change
전환청구권행사 (제15회차)
Korean 9.6 KB
2025-06-05 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 39.8 KB
2025-05-20 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제17회차 CB)
Korean 6.1 KB
2025-05-19 00:00
Capital/Financing Update
[기재정정]주요사항보고서(자본으로인정되는채무증권발행결정)
Korean 41.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all ITOXI Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ITOXI Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ITOXI Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France
OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium
OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan
4766
Passage BIO, Inc. Logo
Developing genetic medicines for severe CNS and neurodegenerative disorders.
United States of America
PASG
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway
PCIB
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye
PCILT
PDS Biotechnology Corp Logo
Developing T-cell activating immunotherapies for cancer and infectious diseases.
United States of America
PDSB
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan
7066
PepGen Inc. Logo
Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.
United States of America
PEPG
PeptiDream Inc. Logo
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan
4587

Talk to a Data Expert

Have a question? We'll get back to you promptly.